a 2005

Identification of lactic acid bacteria isolated from blood samples and their susceptibility to antibiotics

ŠEVČÍKOVÁ, Alena, Pavel ŠVEC, Marc VANCANNEYT, Jean SWINGS, Ivo SEDLÁČEK et. al.

Základní údaje

Originální název

Identification of lactic acid bacteria isolated from blood samples and their susceptibility to antibiotics

Název česky

Identifikace laktobacilů izolovaných z hemokultur a jejich citlivost k antibiotikům

Název anglicky

Identification of lactic acid bacteria isolated from blood samples and their susceptibility to antibiotics

Autoři

ŠEVČÍKOVÁ, Alena (203 Česká republika), Pavel ŠVEC (203 Česká republika), Marc VANCANNEYT (56 Belgie), Jean SWINGS (56 Belgie) a Ivo SEDLÁČEK (203 Česká republika, garant)

Vydání

15th European Congress of Clinical Microbiology and Infectious Disease. Clin Microbiol Infect, Suppl. 2. 2005

Další údaje

Jazyk

čeština

Typ výsledku

Konferenční abstrakt

Obor

10600 1.6 Biological sciences

Stát vydavatele

Dánsko

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14310/05:00013114

Organizační jednotka

Přírodovědecká fakulta

Klíčová slova anglicky

Lactic acid bacteria; identification; susceptibility
Změněno: 24. 3. 2010 13:40, doc. RNDr. Pavel Švec, Ph.D.

Anotace

V originále

Objectives: Since the 1980s members of lactococci, pediococci, leuconostocs and lactobacilli have rarely been indicated as opportunistic pathogens in humans. Generally, these taxa are part of the normal intestinal flora and occur in fermented foods and on plants. Due to their low virulence it is assumed that these bacteria are pathogenic only in immunocompromised hosts. Their sporadic occurrence in human clinical samples is often overlooked and/or they are misidentified. Methods: A total of 59 845 blood samples were isolated at the Department of Clinical Microbiology (Teaching Hospital, Brno, Czech Republic) during the 2000 – 2003. Biochemical identification was performed on selected LAB by API 50 CH kit and by conventional tests. (GTG)5- PCR fingerprinting and whole cell protein profile analysis by SDS-PAGE were performed to confirm the biochemical identification results. The MICs for antimicrobial agents (benzylpenicillin, ampicilin, cefotaxim, imipenem, erytromycin, clindamycin, gentamicin, ciprofloxacin, cotrimoxazol, metronidazol, vancomycin and teikoplanin) were determined by using the E-test MIC (Biodisk, Solna, Sweden). Results: A total of 59.845 investigated blood samples yielded 12.767 (21.3%) infected hemocultures of which 33 (0.25%) contained LAB. They were identified based on phenotypical testing as Lactobacillus plantarum (3 strains), Lactobacillus rhamnosus (7), Lactobacillus paracasei ssp. paracasei (2), Lactobacillus salivarius ssp. salivarius (1), Lactobacillus fermentum (1), Leuconostoc mesenteroides (9), Leuconostoc lactis (5) and Pediococcus pentosaceus (1). The (GTG)5- PCR fingerprinting and whole cell protein profile analysis confirmed above identifications and furthermore identified four strains which were biochemically classified at the genus level as Lactobacillus sakei ssp. carnosus, Lactobacillus curvatus, Leuconostoc pseudomesenteroides and Weissella confusa. All investigated strains (19) were resistant to vancomycin, teicoplanin and metronidazol and most of them to cotrimoxazol. Susceptibility to cefotaxim, imipenem, gentamicin and ciprofloxacin was variable. Conclusion: Lactobacillus rhamnosus and Leuconostoc mesenteroides were the most common LAB species isolated from blood samples. Although isolation of LAB from blood samples is rare, it is of clinical significance and it should be taken into account during treatment decision - especially when they are isolated in pure culture from sterile sites.

Anglicky

Objectives: Since the 1980s members of lactococci, pediococci, leuconostocs and lactobacilli have rarely been indicated as opportunistic pathogens in humans. Generally, these taxa are part of the normal intestinal flora and occur in fermented foods and on plants. Due to their low virulence it is assumed that these bacteria are pathogenic only in immunocompromised hosts. Their sporadic occurrence in human clinical samples is often overlooked and/or they are misidentified. Methods: A total of 59 845 blood samples were isolated at the Department of Clinical Microbiology (Teaching Hospital, Brno, Czech Republic) during the 2000 – 2003. Biochemical identification was performed on selected LAB by API 50 CH kit and by conventional tests. (GTG)5- PCR fingerprinting and whole cell protein profile analysis by SDS-PAGE were performed to confirm the biochemical identification results. The MICs for antimicrobial agents (benzylpenicillin, ampicilin, cefotaxim, imipenem, erytromycin, clindamycin, gentamicin, ciprofloxacin, cotrimoxazol, metronidazol, vancomycin and teikoplanin) were determined by using the E-test MIC (Biodisk, Solna, Sweden). Results: A total of 59.845 investigated blood samples yielded 12.767 (21.3%) infected hemocultures of which 33 (0.25%) contained LAB. They were identified based on phenotypical testing as Lactobacillus plantarum (3 strains), Lactobacillus rhamnosus (7), Lactobacillus paracasei ssp. paracasei (2), Lactobacillus salivarius ssp. salivarius (1), Lactobacillus fermentum (1), Leuconostoc mesenteroides (9), Leuconostoc lactis (5) and Pediococcus pentosaceus (1). The (GTG)5- PCR fingerprinting and whole cell protein profile analysis confirmed above identifications and furthermore identified four strains which were biochemically classified at the genus level as Lactobacillus sakei ssp. carnosus, Lactobacillus curvatus, Leuconostoc pseudomesenteroides and Weissella confusa. All investigated strains (19) were resistant to vancomycin, teicoplanin and metronidazol and most of them to cotrimoxazol. Susceptibility to cefotaxim, imipenem, gentamicin and ciprofloxacin was variable. Conclusion: Lactobacillus rhamnosus and Leuconostoc mesenteroides were the most common LAB species isolated from blood samples. Although isolation of LAB from blood samples is rare, it is of clinical significance and it should be taken into account during treatment decision - especially when they are isolated in pure culture from sterile sites.

Návaznosti

GA301/02/1505, projekt VaV
Název: Molekulární diagnostika, epidemiologie a klasifikace klinicky významných grampozitivních koků
Investor: Grantová agentura ČR, Molekulární diagnostika, epidemiologie a klasifikace klinicky významných grampozitivních koků
MSM0021622416, záměr
Název: Diverzita biotických společenstev a populací: kauzální analýza variability v prostoru a čase
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Diverzita biotických společenstev: kauzální analýza variability v prostoru a čase